21 | Radioisotopes (Radionuclides)IBA
04/2022
-
12/2004 |
17 | RadiopharmaceuticalsIBA
10/2021
-
12/2004 |
10 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2024
-
08/2004 |
8 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021
-
08/2004 |
7 | Peptide Receptors (Peptide Receptor)IBA
04/2022
-
01/2016 |
6 | AcidsIBA
06/2017
-
12/2004 |
6 | PorphyrinsIBA
02/2015
-
02/2010 |
5 | LigandsIBA
06/2022
-
05/2004 |
4 | lutetium ethylenediaminetetramethylene phosphonic acidIBA
10/2021
-
03/2014 |
4 | Durapatite (Hydroxylapatite)IBA
01/2016
-
07/2008 |
4 | phosphonic acidIBA
12/2014
-
04/2008 |
3 | Trastuzumab (Herceptin)FDA Link
04/2024
-
06/2022 |
3 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2022
-
08/2004 |
3 | AntigensIBA
10/2021
-
01/2016 |
3 | DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotateIBA
03/2021
-
09/2020 |
3 | lutetium Lu 177 dotatateIBA
01/2021
-
01/2016 |
3 | ThyroglobulinFDA Link
01/2021
-
05/2015 |
3 | 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA
01/2018
-
12/2013 |
2 | Rituximab (Mabthera)FDA Link
09/2023
-
01/2017 |
2 | LutetiumIBA
04/2022
-
07/2011 |
2 | 177Lu-PSMA-617IBA
04/2021
-
12/2019 |
2 | Hemoglobins (Hemoglobin)IBA
01/2021
-
01/2016 |
2 | EndotoxinsIBA
01/2020
-
11/2014 |
2 | Tumor Biomarkers (Tumor Markers)IBA
10/2019
-
01/2016 |
2 | Peptides (Polypeptides)IBA
01/2018
-
03/2013 |
2 | Organophosphonates (Phosphonates)IBA
01/2018
-
05/2004 |
2 | IntegrinsIBA
03/2017
-
03/2013 |
2 | AntibodiesIBA
01/2017
-
07/2005 |
2 | 177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA
12/2016
-
09/2008 |
2 | MetalsIBA
01/2016
-
09/2008 |
2 | MisonidazoleIBA
03/2015
-
03/2013 |
2 | fluoromisonidazoleIBA
03/2015
-
08/2014 |
2 | iminodiacetic acidIBA
08/2014
-
12/2006 |
2 | ColchicineFDA LinkGeneric
08/2014
-
02/2006 |
2 | NitroimidazolesIBA
08/2014
-
07/2005 |
2 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
08/2014
-
02/2006 |
2 | Androgen Receptors (Androgen Receptor)IBA
10/2011
-
11/2006 |
2 | Estrogen ReceptorsIBA
07/2011
-
07/2005 |
2 | Ethiodized Oil (Ethiodol)FDA Link
10/2010
-
05/2009 |
2 | Metronidazole (Metric)FDA LinkGeneric
07/2005
-
02/2003 |
1 | AntiemeticsIBA
02/2024 |
1 | Humanized Monoclonal AntibodiesIBA
09/2023 |
1 | Lutetium-177IBA
09/2023 |
1 | AutoantibodiesIBA
10/2022 |
1 | Iodide Peroxidase (Deiodinase)IBA
10/2022 |
1 | anti-thyroglobulinIBA
10/2022 |
1 | pertuzumabIBA
06/2022 |
1 | human ERBB2 proteinIBA
06/2022 |
1 | Hormones (Hormone)IBA
10/2021 |
1 | gallium 68 PSMA-11IBA
04/2021 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 |
1 | Fibroins (Fibroin)IBA
12/2020 |
1 | AndrogensIBA
01/2020 |
1 | Monoclonal AntibodiesIBA
12/2019 |
1 | 131I-rituximabIBA
12/2019 |
1 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
05/2019 |
1 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
05/2019 |
1 | Androgen Antagonists (Antiandrogens)IBA
12/2018 |
1 | jugloneIBA
09/2018 |
1 | Ascorbic Acid (Vitamin C)FDA LinkGeneric
09/2018 |
1 | CatalaseIBA
09/2018 |
1 | CD13 Antigens (Alanine Aminopeptidase)IBA
01/2018 |
1 | NGR peptideIBA
01/2018 |